Newspaper/Magazine Article

FDA Advise-ERR: prevent dangerous drug-device interaction causing falsely elevated glucose levels.

Institute for Safe Medication Practices; ISMP.

This article addresses a drug–device interaction in which patients receiving a certain peritoneal dialysis solution may have falsely elevated blood glucose levels when measured with point-of-care blood glucose monitors.